Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENRAS – Genetics of Response to Agomelatine vs. Escitalopram
2010-019423-61Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in major depressive disorder (MDD) comparing Agomelatine arm with Escitalopram arm (2 arms). Primary endpoint: Genetic determinants of antidepressant response. Started Sep 2010; status: completed.
02
Drugs
agomelatineescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2010-019423-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019423-61.